A PILOT STUDY OF THE EFFECTS OF CANNABIS ON APPETITE HORMONES IN HIV-INFECTED ADULT MEN
Patricia K. Riggs, Florin Vaida, Steven S. Rossi, Linda S. Sorkin, Ben Gouaux, Igor Grant, and Ronald J. Ellisa.
Brain Research 2012 Jan 11; 1431: 46–52.
The aim of this placebo-controlled trial was to evaluate the effects of medicinal cannabis on the appetite hormones including ghrelin, leptin and insulin as well as on PYY (peptide tyrosine tyrosine). The results show that medicinal cannabis can significantly affect levels of the appetite hormones and be considered as a supporting medicine when treating eating disorders and obesity.
Pre-clinical studies documenting the anti-cancer effects of THC and its success in inhibiting cancer growth and spread have been on the rise. Clinical studies however are scarce as the psychoactive effects of THC can limit its medicinal and clinical use. Could non-psychoactive cannabinoids found in cannabis and hemp be the answer to treating cancer instead?
At ANTG, we are uniquely well-positioned to supply the domestic market and become the first medicinal cannabis company in Australia to export cannabis flower for commercial purposes to the EU. Interested in investing in medicinal cannabis? Read what sets ANTG apart.